Cognition Therapeutics Inc (CGTX) Financials

$0.98

$0.00 (0.32%)

As on 11-Sep-2026 16:00EDT

Market cap

$98 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

2.9

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	0.19	0.23	0.27	0.25	0.24	0.09
Gross Profit	-0.19	-0.23	-0.27	-0.25	-0.24	-0.09
Operating Expenses	36.47	47.80	53.97	50.72	43.32	28.60
Operating Profit (EBIT)	-36.60	-47.80	-53.97	-50.72	-43.55	-28.60
Other Income	--	--	--	--	-0.04	--
Profit before Tax	-16.78	-23.49	-33.97	-25.79	-21.40	-11.72
Provision for Tax	--	--	--	--	-22.15	-1.43
Profit after Tax (Net Income)	-16.78	-23.49	-33.97	-25.79	0.76	-11.72
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-21.40	-16.25

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	33.02	34.27	18.75	24.47	40.25	51.27
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.42	0.20	0.34	0.52	2.38	4.17
Current Liabilities	5.45	13.92	11.14	10.17	7.80	7.86
Total Liabilities	44.35	48.39	30.23	35.16	50.43	59.14

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	0.60	0.40	0.68	0.94	2.78	0.15
Current Assets	38.30	47.99	29.56	34.22	47.65	58.99
Total Assets	44.35	48.39	30.23	35.16	50.43	59.14
Total Debt*	0.51	0.64	0.81	1.24	1.48	--
Net Current Assets	32.85	34.07	18.41	24.05	39.85	51.13

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-24.59	-28.47	-16.02	-18.53	-3.63
Cash Flow from Investing Activities	--	0.01	0.00	-0.15	-0.17	-0.03
Cash from Financing Activities	--	36.57	23.57	4.52	5.55	53.20
Net Cash Inflow / Outflow	--	--	--	--	-13.16	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-0.20	-0.26	-0.73	-0.84	0.03	-0.56
Cash EPS ($)	--	-0.26	-0.73	-0.83	0.03	-0.55
Adjusted Book Value ($)	--	0.39	0.40	0.80	1.39	2.45
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.28	-0.61	-0.52	-0.64	-0.17
Free Cash Flow per Share ($)	--	-0.28	-0.61	-0.53	-0.65	-0.17

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-86.23	-150.06	-76.48	1.63	577.29
ROE (%)	-49.86	-88.60	-157.19	-79.69	1.65	138.56
ROA (%)	-43.95	-59.75	-103.89	-60.26	1.38	-35.37
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	-2,162.86	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	61.08	30.85	-31.77	-20.55	-97.44	-77.78
Net Profit Growth (%)	49.16	30.86	-31.73	-3,506.61	106.46	-16.32
EPS Growth (%)	70.28	0.64	0.13	-33.09	1.05	-0.16
Book Value Growth (%)	230.19	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-5.11	-0.96	-2.21	80.43	-11.30
Price / Book Value	2.91	3.50	1.74	2.33	1.51	2.58
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.44	-3.61	-0.25	-1.11	-0.98	-7.24
Close Price ($)	1.15	1.35	0.70	1.85	2.10	6.32
High Price ($)	3.83	3.83	2.95	3.49	7.30	13.80
Low Price ($)	0.29	0.22	0.34	0.90	1.07	4.68
Market Cap ($ Cr)	97.95	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.02	0.04	0.05	0.04	--
Short term debt to equity ratio	0.00	0.01	0.03	0.03	0.02	0.01
Current Ratio	7.03	3.45	2.65	3.37	6.11	7.50
Quick Ratio	7.03	--	--	--	--	7.25
Interest Coverage	-1,289.38	-1,805.69	-1,357.84	-954.11	-763.18	-12.12

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	3,099.19	4,983.90
Payable days	--	2,485.46	3,898.98	5,008.42	5,738.31	12,118.05
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.